These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice. Sedgmen BJ, Dawicki W, Gommerman JL, Pfeffer K, Watts TH. Int Immunol; 2006 May; 18(5):797-806. PubMed ID: 16569673 [Abstract] [Full Text] [Related]
29. IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells. Denton AE, Doherty PC, Turner SJ, La Gruta NL. Eur J Immunol; 2007 Feb; 37(2):368-75. PubMed ID: 17219365 [Abstract] [Full Text] [Related]
31. [Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses]. Rekstin AR, Lu K, Kats D, Rudenko LG. Vopr Virusol; 2006 Feb; 51(2):27-30. PubMed ID: 16756175 [Abstract] [Full Text] [Related]
32. Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination. Guiton R, Zagani R, Dimier-Poisson I. Parasite Immunol; 2009 Oct; 31(10):631-40. PubMed ID: 19751475 [Abstract] [Full Text] [Related]
33. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies. Lo CY, Wu Z, Misplon JA, Price GE, Pappas C, Kong WP, Tumpey TM, Epstein SL. Vaccine; 2008 Apr 16; 26(17):2062-72. PubMed ID: 18378366 [Abstract] [Full Text] [Related]
34. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B. Vaccine; 2008 Jun 02; 26(23):2912-8. PubMed ID: 18448208 [Abstract] [Full Text] [Related]
36. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection. Garulli B, Meola M, Stillitano MG, Kawaoka Y, Castrucci MR. Virology; 2007 May 10; 361(2):274-82. PubMed ID: 17222437 [Abstract] [Full Text] [Related]
37. Reverse genetics studies of attenuation of the ca A/AA/6/60 influenza virus: the role of the matrix gene. Sweet TM, Maassab HF, Herlocher ML. Biomed Pharmacother; 2004 Nov 10; 58(9):509-15. PubMed ID: 15511608 [Abstract] [Full Text] [Related]
38. DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza. Williman J, Young S, Buchan G, Slobbe L, Wilson M, Pang P, Austyn J, Preston S, Baird M. Vaccine; 2008 Sep 19; 26(40):5153-8. PubMed ID: 18456374 [Abstract] [Full Text] [Related]
39. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis. Sharma SK, Dube A, Nadeem A, Khan S, Saleem I, Garg R, Mohammad O. Vaccine; 2006 Mar 10; 24(11):1800-10. PubMed ID: 16310900 [Abstract] [Full Text] [Related]
40. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model. Babiuk S, Skowronski DM, De Serres G, HayGlass K, Brunham RC, Babiuk L. J Med Virol; 2004 Jan 10; 72(1):138-42. PubMed ID: 14635022 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]